CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
We received an updated WNV package insert; please note the manufacturer and license number has been ...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...